These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1450 related articles for article (PubMed ID: 28526997)

  • 21. Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis.
    Turola E; Petta S; Vanni E; Milosa F; Valenti L; Critelli R; Miele L; Maccio L; Calvaruso V; Fracanzani AL; Bianchini M; Raos N; Bugianesi E; Mercorella S; Di Giovanni M; Craxì A; Fargion S; Grieco A; Cammà C; Cotelli F; Villa E
    Dis Model Mech; 2015 Sep; 8(9):1037-46. PubMed ID: 26183212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.
    Fargion S; Porzio M; Fracanzani AL
    World J Gastroenterol; 2014 Oct; 20(37):13306-24. PubMed ID: 25309067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effects of white button mushroom (Agaricus bisporus) against hepatic steatosis in ovariectomized mice as a model of postmenopausal women.
    Kanaya N; Kubo M; Liu Z; Chu P; Wang C; Yuan YC; Chen S
    PLoS One; 2011; 6(10):e26654. PubMed ID: 22046322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
    Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
    BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
    Wu J
    Oncotarget; 2016 Jul; 7(27):42762-42776. PubMed ID: 27072576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic syndrome and chronic liver disease.
    Rosselli M; Lotersztajn S; Vizzutti F; Arena U; Pinzani M; Marra F
    Curr Pharm Des; 2014; 20(31):5010-24. PubMed ID: 24320032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.
    Jiang ZG; Tapper EB; Connelly MA; Pimentel CF; Feldbrügge L; Kim M; Krawczyk S; Afdhal N; Robson SC; Herman MA; Otvos JD; Mukamal KJ; Lai M
    Liver Int; 2016 Aug; 36(8):1213-20. PubMed ID: 26815314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
    Pierantonelli I; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
    Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J
    Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.
    Santos RD; Valenti L; Romeo S
    Atherosclerosis; 2019 Mar; 282():110-120. PubMed ID: 30731283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-weaning exposure to high-sucrose diet induces early non-alcoholic fatty liver disease onset and progression in male mice: role of dysfunctional white adipose tissue.
    França LM; Dos Santos PC; Barroso WA; Gondim RSD; Coêlho CFF; Flister KFT; Paes AMA
    J Dev Orig Health Dis; 2020 Oct; 11(5):509-520. PubMed ID: 32594969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The common marmoset as a model for the study of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Kramer JA; Grindley J; Crowell AM; Makaron L; Kohli R; Kirby M; Mansfield KG; Wachtman LM
    Vet Pathol; 2015 Mar; 52(2):404-13. PubMed ID: 24913270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.
    Ikawa-Yoshida A; Matsuo S; Kato A; Ohmori Y; Higashida A; Kaneko E; Matsumoto M
    Int J Exp Pathol; 2017 Aug; 98(4):221-233. PubMed ID: 28895242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.
    Lonardo A; Nascimbeni F; Ballestri S; Fairweather D; Win S; Than TA; Abdelmalek MF; Suzuki A
    Hepatology; 2019 Oct; 70(4):1457-1469. PubMed ID: 30924946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex differences in the impact of nonalcoholic fatty liver disease on cardiovascular risk factors.
    Du T; Sun X; Yuan G; Zhou X; Lu H; Lin X; Yu X
    Nutr Metab Cardiovasc Dis; 2017 Jan; 27(1):63-69. PubMed ID: 27956025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLD.
    Sarkar MA; Suzuki A; Abdelmalek MF; Yates KP; Wilson LA; Bass NM; Gill R; Cedars M; Terrault N;
    Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1267-1274.e1. PubMed ID: 33010412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Santos ME; Nahas EA
    Gynecol Endocrinol; 2014 May; 30(5):325-9. PubMed ID: 24460502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.